Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEO

0
100
Novo ​Nordisk plans ‌to seek Chinese ​regulatory ​approval for its ⁠weight-loss ​pill “very soon,” ​CEO Mike Doustdar said ​Tuesday, ​in a move ‌to ⁠catch up with rival ​Eli ​Lilly ⁠in the ​world’s ​second-largest ⁠pharmaceutical market.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here